(Q54355360)

28 May 2018

title

The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions. (English)

1 reference

28 May 2018

main subject

angiogenesis inhibitor

1 reference

4

1 reference

28 May 2018

author name string

Mary Drinane

1

1 reference

28 May 2018

Jannine Walsh

2

1 reference

28 May 2018

Jessica Mollmark

3

1 reference

28 May 2018

Mary Jo Mulligan-Kehoe

5

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 September 2006

1 reference

28 May 2018

Journal of Biological Chemistry

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 May 2018

volume

281

1 reference

28 May 2018

issue

44

1 reference

28 May 2018

page(s)

33336-33344

1 reference

28 May 2018

Fundamental Concepts of the Angiogenic Process

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Apoptotic cues from the extracellular matrix: regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Endogenous angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Anticancer drug targets: approaching angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Serine/threonine protein kinases and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

The role of the ubiquitin-proteasome pathway in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Fibroblast growth factor-specific modulation of cellular response by syndecan-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Syndecan-4-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Syndecans: new kids on the signaling block

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Integrative signaling in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Cellular signaling by fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Vital functions for lethal caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

Apoptosis: the sculptor of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607097200

21 January 2018

Identifiers

DOI

10.1074/JBC.M607097200

1 reference

28 May 2018

1 reference

28 May 2018